Pulse Biosciences, Inc. (PLSE)
47.90
-1.93
(-3.87%)
USD |
NASDAQ |
Oct 02, 16:00
47.91
+0.01
(+0.02%)
After-Hours: 20:00
Pulse Biosciences Shareholders Equity (Quarterly) : 99.50M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 99.50M |
| March 31, 2026 | 66.30M |
| December 31, 2025 | 80.66M |
| September 30, 2025 | 92.69M |
| June 30, 2025 | 104.49M |
| March 31, 2025 | 118.45M |
| December 31, 2024 | 114.86M |
| September 30, 2024 | 79.13M |
| June 30, 2024 | 26.97M |
| March 31, 2024 | 36.29M |
| December 31, 2023 | 44.36M |
| September 30, 2023 | 52.14M |
| June 30, 2023 | 60.50M |
| March 31, 2023 | -10.67M |
| December 31, 2022 | -2.248M |
| September 30, 2022 | 6.189M |
| June 30, 2022 | 23.42M |
| March 31, 2022 | 20.80M |
| December 31, 2021 | 35.69M |
| September 30, 2021 | 47.39M |
| June 30, 2021 | 59.75M |
| Date | Value |
|---|---|
| March 31, 2021 | 20.40M |
| December 31, 2020 | 22.89M |
| September 30, 2020 | 32.70M |
| June 30, 2020 | 42.33M |
| March 31, 2020 | 21.77M |
| December 31, 2019 | 30.74M |
| September 30, 2019 | 40.98M |
| June 30, 2019 | 49.86M |
| March 31, 2019 | 59.11M |
| December 31, 2018 | 66.33M |
| September 30, 2018 | 28.07M |
| June 30, 2018 | 35.05M |
| March 31, 2018 | 41.10M |
| December 31, 2017 | 46.00M |
| September 30, 2017 | 49.94M |
| June 30, 2017 | 24.16M |
| March 31, 2017 | 27.33M |
| December 31, 2016 | 25.30M |
| September 30, 2016 | 27.86M |
| June 30, 2016 | 30.47M |
| March 31, 2016 | 12.17M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Lucid Diagnostics, Inc. | 10.93M |
| Accuray, Inc. | 41.70M |
| Micron Solutions, Inc. | -- |
| IDEXX Laboratories, Inc. | 1.613B |
| Neogen Corp. | 2.093B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 115.56M |
| Total Liabilities (Quarterly) | 16.06M |
| Debt to Equity Ratio | 0.0681 |
| Current Ratio | 9.628 |
| Net Debt Paydown Yield | 0.02% |